What is Assisted Reproductive Technology Market?
Assisted reproductive technology is included fertility treatments that handle both a woman's egg and a man's sperm. This technique involves surgically removing eggs from a woman’s ovaries, combining them with sperm in the laboratory, and returning them to the woman’s body or donating them to another woman. The most common and effective type of the assisted reproductive technology is in vitro fertilization (IVF). The factors such as Increased Prevalence of Infertility due to High Stress, Obesity, and Other Reasons and Increased Number of People with Sedatory Lifestyle are driving the global Assisted Reproductive Technology market. Also, the Growing Demand for In Vitro Fertilization (IVF) Technique fueling the market growth. However, Multiple Pregnancy due to Assisted Reproductive Technology is a Common Complication that may restrain the growth of the global Assisted Reproductive Technology market.
The market study is being classified by Type (General, Fertility Medication, In Vitro Fertilization and Others), by Application (Fertility Clinics, Hospitals and Others) and major geographies with country level break-up.
Thermo Fisher Scientific (United States), Vitrolife (Sweden), Cosmos Biomedical Ltd. (United Kingdom), Ferring Pharmaceuticals (Switzerland), Nidacon International AB (Sweden), Irvine Scientific (United States), Merck Group (Germany), Cook Medical (United States), INVO Bioscience (United States) and Smiths Medical (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are EMD Serono Inc. (United States) and IVFtech (Denmark).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Assisted Reproductive Technology market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Assisted Reproductive Technology market by Type, Application and Region.
On the basis of geography, the market of Assisted Reproductive Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Infertility due to High Stress, Obesity, and Other Reasons
- Increased Number of People with Sedatory Lifestyle
- Growing Demand for In Vitro Fertilization (IVF) Technique
- Multiple Pregnancy due to Assisted Reproductive Technology is a Common Complication
- Growing Number of Fertility Centres across the Globe
- Increasing Research and Development Investments
- Less Awareness about Benefits of Assisted Reproductive Technology among People in Some Regions
Market Leaders and some development strategies
In March 2020, Thermo Fisher Scientific Inc., the world leader in serving science, and QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies, has announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN.
Key Target AudienceAssisted Reproductive Technology Providers, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase